Is 99mTc-diphosphonate uptake the earliest sign of cardiac amyloidosis development in asymptomatic Glu89Gln transthyretin gene mutation carriers?
Main Authors: | Minutoli, Fabio, Mazzeo, Anna, Di Bella, Gianluca, Vita, Giuseppe, Baldari, Sergio |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642038/ |
Similar Items
-
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis
by: Di Bella, Gianluca, et al.
Published: (2015) -
Cardiac involvement and clinical follow up of patients with hereditary transthyretin related amyloidosis associated with Glu89Gln mutation
by: Gospodinova, Mariana, et al.
Published: (2015) -
Glu89Gln transthyretin-related amyloidosis in Italy and Bulgaria: does geographic area influence phenotype beyond the shared mutation?
by: Gagliardi, Christian, et al.
Published: (2015) -
99mTc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis
by: Pilebro, Björn, et al.
Published: (2016) -
Usefulness of combining electrocardiogram and echocardiography findings and brain natriuretic peptide in early detection of cardiac amyloidosis in subjects with transthyretin gene mutation
by: Di Bella, Gianluca, et al.
Published: (2015)